United States Pharmaceuticals

Elanco Animal Health Inc (ELAN)

Track

Track

Elanco Animal Health witnessed significant insider buying activity over the past ninety days, totaling approximately 1.47 million dollars. Five individuals acquired shares following a positive earnings report. Despite a 7.4 percent decline in stock value recently, these transactions reflect internal confidence without any recorded sales during this specific period.
Ticker: ELAN Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Elanco Animal Health Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.7
Kurzius Lawrence Erik Non-Executive Director
Transaction date
Purchase
Price
472.31
Quantity 90,439 -25.7%
Value US$3,155,412
O'Neill Shiv GC AND CORP SEC Officer
Transaction date
Purchase
Price
25.55
Quantity 28,420 -4.3%
Value US$473,447
2.5
Harrington Michael J Non-Executive Director
Transaction date
Purchase
Price
453.61
Quantity 32,880 -35.1%
Value US$4,548,282
2.5
VanHimbergen Robert M EVP and CFO Officer
Transaction date
Purchase
Price
23.08
Quantity 4,200 +3.2%
Value US$96,926
1.2
Herendeen Paul Non-Executive Director
Transaction date
Purchase
Price
23.69
Quantity 10,000 +9.8%
Value US$236,850
2.4
Modi Rajeev A. SEE REMARKS Officer
Transaction date
Purchase
Price
20.35
Quantity 4,911 +3.2%
Value US$99,939
3.5
Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR Executive Director
Transaction date
Purchase
Price
20.09
Quantity 4,971 +3.0%
Value US$99,843
3.7
Kurzius Lawrence Erik Non-Executive Director
Transaction date
Purchase
Price
21.30
Quantity 10,000 +8.2%
Value US$213,000
2.5
VanHimbergen Robert M EVP and CFO Officer
Transaction date
Purchase
Price
21.64
Quantity 6,950 +5.9%
Value US$150,426
2.4
Modi Rajeev A. SEE REMARKS Officer
Transaction date
Planned purchase
Price
21.33
Quantity 4,500 +3.8%
Value US$95,985
3.5
Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR Executive Director
Transaction date
Purchase
Price
21.75
Quantity 22,000 +15.2%
Value US$478,496
3.7
Kurzius Lawrence Erik Non-Executive Director
Transaction date
Purchase
Price
10.20
Quantity 10,000 +9.9%
Value US$102,000
3.7
Kurzius Lawrence Erik Non-Executive Director
Transaction date
Purchase
Price
10.90
Quantity 10,000 +10.9%
Value US$109,000
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
10.90
Quantity 25,000 +13.5%
Value US$272,558
2.5
Harrington Michael J Non-Executive Director
Transaction date
Purchase
Price
14.85
Quantity 3,500 +4.5%
Value US$51,974
3.5
Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR Executive Director
Transaction date
Purchase
Price
13.01
Quantity 100,000 +222.2%
Value US$1,300,610
2.2
DOYLE WILLIAM F Non-Executive Director
Transaction date
Purchase
Price
16.98
Quantity 15,000 +24.5%
Value US$254,700
2.2
DOYLE WILLIAM F Non-Executive Director
Transaction date
Purchase
Price
16.30
Quantity 15,000 +32.4%
Value US$244,500
2.5
Harrington Michael J Non-Executive Director
Transaction date
Purchase
Price
16.29
Quantity 3,100 +4.2%
Value US$50,494
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
16.14
Quantity 20,000 +12.1%
Value US$322,808
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
9.55
Quantity 5,000 +3.1%
Value US$47,750
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
9.46
Quantity 5,000 +3.2%
Value US$47,288
3.5
Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR Executive Director
Transaction date
Purchase
Price
9.60
Quantity 15,000 +50.0%
Value US$143,972
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
11.13
Quantity 10,000 +6.9%
Value US$111,300
3.3
BILBREY JOHN P Non-Executive Director
Transaction date
Purchase
Price
13.24
Quantity 7,500 +21.9%
Value US$99,267
2.4
Modi Rajeev A. SEE REMARKS Officer
Transaction date
Purchase
Price
14.90
Quantity 6,700 +19.4%
Value US$99,830
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
15.18
Quantity 20,000 +16.0%
Value US$303,614
1.2
Herendeen Paul Non-Executive Director
Transaction date
Purchase
Price
15.03
Quantity 10,000 +136.9%
Value US$150,250
3.5
Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR Executive Director
Transaction date
Purchase
Price
14.54
Quantity 30,000 +inf%
Value US$436,146
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
23.33
Quantity 10,000 +8.7%
Value US$233,269
3.3
BILBREY JOHN P Non-Executive Director
Transaction date
Purchase
Price
22.03
Quantity 10,000 +41.3%
Value US$220,284
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
29.00
Quantity 5,000 +4.5%
Value US$145,000
1.8
Anand Kapila K Non-Executive Director
Transaction date
Purchase
Price
28.48
Quantity 1,000 +3.8%
Value US$28,479
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
28.66
Quantity 5,000 +4.8%
Value US$143,322
2.5
Harrington Michael J Non-Executive Director
Transaction date
Purchase
Price
29.25
Quantity 2,500 +9.7%
Value US$73,122
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
29.38
Quantity 10,000 +10.5%
Value US$293,794
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
31.79
Quantity 5,000 +5.6%
Value US$158,934
2.9
HOOVER R DAVID See Remarks Non-Executive Director
Transaction date
Purchase
Price
32.44
Quantity 25,000 +55.6%
Value US$811,000
1.6
BAYER AKTIENGESELLSCHAFT Large shareholder
Transaction date
Sale
Price
29.84
Quantity 54,500,000 -74.7%
Value US$1,626,367,200
2.9
HOOVER R DAVID See Remarks Non-Executive Director
Transaction date
Purchase
Price
28.62
Quantity 5,000 +12.5%
Value US$143,100
2.9
HOOVER R DAVID See Remarks Non-Executive Director
Transaction date
Purchase
Price
28.24
Quantity 5,000 +16.1%
Value US$141,200
2.9
HOOVER R DAVID See Remarks Non-Executive Director
Transaction date
Purchase
Price
26.94
Quantity 10,000 +47.4%
Value US$269,400
3.3
BILBREY JOHN P Non-Executive Director
Transaction date
Purchase
Price
26.20
Quantity 9,580 +65.4%
Value US$250,996
3.4
GARCIA ART A Non-Executive Director
Transaction date
Purchase
Price
24.76
Quantity 2,000 +28.3%
Value US$49,520
3.6
YOUNG TODD S. See Remarks Officer
Transaction date
Purchase
Price
23.94
Quantity 5,000 +inf%
Value US$119,700
3.6
YOUNG TODD S. See Remarks Officer
Transaction date
Purchase
Price
23.85
Quantity 2,000 +inf%
Value US$47,700
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
21.97
Quantity 12,000 +42.9%
Value US$263,640
2.5
Harrington Michael J Non-Executive Director
Transaction date
Purchase
Price
23.84
Quantity 4,000 +31.3%
Value US$95,360
3.3
BILBREY JOHN P Non-Executive Director
Transaction date
Purchase
Price
25.15
Quantity 3,000 +25.8%
Value US$75,450
1.8
Anand Kapila K Non-Executive Director
Transaction date
Purchase
Price
26.86
Quantity 1,000 +8.1%
Value US$26,860
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
27.40
Quantity 3,900 +16.2%
Value US$106,860
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
26.99
Quantity 4,100 +20.5%
Value US$110,659
BILBREY JOHN P Non-Executive Director
Transaction date
Purchase
Price
26.58
Quantity 3,766 +47.8%
Value US$100,100
2.3
Urbanek David Alan See Remarks
Transaction date
Purchase
Price
26.29
Quantity 76 +inf%
Value US$1,998
2.3
Urbanek David Alan See Remarks
Transaction date
Purchase
Price
26.27
Quantity 76 +inf%
Value US$1,996
2.3
Urbanek David Alan See Remarks
Transaction date
Purchase
Price
26.21
Quantity 76 +inf%
Value US$1,992
2.0
Kochevar Deborah Turner
Transaction date
Purchase
Price
27.95
Quantity 1,000 +35.9%
Value US$27,950
3.6
YOUNG TODD S. See Remarks
Transaction date
Purchase
Price
26.57
Quantity 10,000 +53.0%
Value US$265,700
3.5
Simmons Jeffrey N President, CEO & Director Executive Director
Transaction date
Purchase
Price
26.55
Quantity 75,750 +19.2%
Value US$2,011,162
Hicks Michael-Bryant See Remarks Officer
Transaction date
Purchase
Price
26.65
Quantity 11,030 +48.2%
Value US$293,905
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
26.96
Quantity 15,000 +1630.4%
Value US$404,400
3.3
BILBREY JOHN P Non-Executive Director
Transaction date
Purchase
Price
32.39
Quantity 7,750 +inf%
Value US$251,022
Harrington Michael J Non-Executive Director
Transaction date
Purchase
Price
26.75
Quantity 3,500 +125.8%
Value US$93,608
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
31.43
Quantity 20,000 +inf%
Value US$628,586
Kinard David S See Remarks Officer
Transaction date
Purchase
Price
0.00
Quantity 7,977
Value US$0
Schacht Aaron L See Remarks Officer
Transaction date
Purchase
Price
0.00
Quantity 1,227
Value US$0
3.5
Simmons Jeffrey N Presiident, CEO & Director Executive Director
Transaction date
Purchase
Price
0.00
Quantity 37,301
Value US$0
2.3
Urbanek David Alan See Remarks Officer
Transaction date
Purchase
Price
0.00
Quantity 2,021
Value US$0
Cabral Ramiro Martin See Remarks Officer
Transaction date
Purchase
Price
0.00
Quantity 1,227
Value US$0
2.9
HOOVER R DAVID Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 920
Value US$0
Meer James M Chief Accounting Officer
Transaction date
Purchase
Price
24.00
Quantity 225 +inf%
Value US$5,400
Urbanek David Alan See Remarks
Transaction date
Purchase
Price
24.00
Quantity 500 +inf%
Value US$12,000
Anand Kapila K
Transaction date
Purchase
Price
24.00
Quantity 1,200 +inf%
Value US$28,800
Kinard David S See Remarks
Transaction date
Purchase
Price
24.00
Quantity 2,500 +inf%
Value US$60,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-21 2026-08-20 B Purchase
3.7
Kurzius Lawrence Erik
Non-Executive Director
90,439 -25.7%
472.31
US$3,155,412 		90,439 -25.7% 472.31 US$3,155,412
2026-08-18 2026-08-18 B Purchase
O'Neill Shiv

GC AND CORP SEC

Officer
28,420 -4.3%
25.55
US$473,447 		28,420 -4.3% 25.55 US$473,447
2026-08-13 2026-08-12 B Purchase
2.5
Harrington Michael J
Non-Executive Director
32,880 -35.1%
453.61
US$4,548,282 		32,880 -35.1% 453.61 US$4,548,282
2026-08-10 2026-08-07 B Purchase
2.5
VanHimbergen Robert M

EVP and CFO

Officer
4,200 +3.2%
23.08
US$96,926 		4,200 +3.2% 23.08 US$96,926
2026-08-10 2026-08-07 B Purchase
1.2
Herendeen Paul
Non-Executive Director
10,000 +9.8%
23.69
US$236,850 		10,000 +9.8% 23.69 US$236,850
2026-05-19 2026-05-15 B Purchase
2.4
Modi Rajeev A.

SEE REMARKS

Officer
4,911 +3.2%
20.35
US$99,939 		4,911 +3.2% 20.35 US$99,939
2026-05-19 2026-05-15 B Purchase
3.5
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
4,971 +3.0%
20.09
US$99,843 		4,971 +3.0% 20.09 US$99,843
2025-12-16 2025-12-12 B Purchase
3.7
Kurzius Lawrence Erik
Non-Executive Director
10,000 +8.2%
21.30
US$213,000 		10,000 +8.2% 21.30 US$213,000
2025-12-15 2025-12-11 B Purchase
2.5
VanHimbergen Robert M

EVP and CFO

Officer
6,950 +5.9%
21.64
US$150,426 		6,950 +5.9% 21.64 US$150,426
2025-12-15 2025-12-11 PP Planned purchase
2.4
Modi Rajeev A.

SEE REMARKS

Officer
4,500 +3.8%
21.33
US$95,985 		4,500 +3.8% 21.33 US$95,985
2025-12-15 2025-12-11 B Purchase
3.5
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
22,000 +15.2%
21.75
US$478,496 		22,000 +15.2% 21.75 US$478,496
2025-08-11 2025-08-11 PrS Proposed sale
3.6
Todd S and Jennifer G Young Living Trust Dtd 08/03/2021

Former CFO
49,333
16.82
US$830,000 		49,333 16.82 US$830,000
2025-03-11 2025-03-11 B Purchase
3.7
Kurzius Lawrence Erik
Non-Executive Director
10,000 +9.9%
10.20
US$102,000 		10,000 +9.9% 10.20 US$102,000
2025-03-11 2025-03-07 B Purchase
3.7
Kurzius Lawrence Erik
Non-Executive Director
10,000 +10.9%
10.90
US$109,000 		10,000 +10.9% 10.90 US$109,000
2025-03-07 2025-03-05 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
25,000 +13.5%
10.90
US$272,558 		25,000 +13.5% 10.90 US$272,558
2024-08-26 2024-08-22 B Purchase
2.5
Harrington Michael J
Non-Executive Director
3,500 +4.5%
14.85
US$51,974 		3,500 +4.5% 14.85 US$51,974
2024-08-13 2024-08-12 B Purchase
3.5
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
100,000 +222.2%
13.01
US$1,300,610 		100,000 +222.2% 13.01 US$1,300,610
2024-05-23 2024-05-21 B Purchase
2.2
DOYLE WILLIAM F
Non-Executive Director
15,000 +24.5%
16.98
US$254,700 		15,000 +24.5% 16.98 US$254,700
2024-03-12 2024-03-08 B Purchase
2.2
DOYLE WILLIAM F
Non-Executive Director
15,000 +32.4%
16.30
US$244,500 		15,000 +32.4% 16.30 US$244,500
2024-03-12 2024-03-08 B Purchase
2.5
Harrington Michael J
Non-Executive Director
3,100 +4.2%
16.29
US$50,494 		3,100 +4.2% 16.29 US$50,494
2024-03-08 2024-03-06 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
20,000 +12.1%
16.14
US$322,808 		20,000 +12.1% 16.14 US$322,808
2023-03-15 2023-03-14 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +3.1%
9.55
US$47,750 		5,000 +3.1% 9.55 US$47,750
2023-03-15 2023-03-13 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +3.2%
9.46
US$47,288 		5,000 +3.2% 9.46 US$47,288
2023-03-13 2023-03-10 B Purchase
3.5
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
15,000 +50.0%
9.60
US$143,972 		15,000 +50.0% 9.60 US$143,972
2023-03-07 2023-03-03 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
10,000 +6.9%
11.13
US$111,300 		10,000 +6.9% 11.13 US$111,300
2022-11-15 2022-11-11 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
7,500 +21.9%
13.24
US$99,267 		7,500 +21.9% 13.24 US$99,267
2022-09-09 2022-09-09 B Purchase
2.4
Modi Rajeev A.

SEE REMARKS

Officer
6,700 +19.4%
14.90
US$99,830 		6,700 +19.4% 14.90 US$99,830
2022-09-09 2022-09-09 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
20,000 +16.0%
15.18
US$303,614 		20,000 +16.0% 15.18 US$303,614
2022-09-09 2022-09-09 B Purchase
1.2
Herendeen Paul
Non-Executive Director
10,000 +136.9%
15.03
US$150,250 		10,000 +136.9% 15.03 US$150,250
2022-09-09 2022-09-09 B Purchase
3.5
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
30,000 +inf%
14.54
US$436,146 		30,000 +inf% 14.54 US$436,146
2022-05-24 2022-05-20 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
10,000 +8.7%
23.33
US$233,269 		10,000 +8.7% 23.33 US$233,269
2022-05-13 2022-05-11 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
10,000 +41.3%
22.03
US$220,284 		10,000 +41.3% 22.03 US$220,284
2022-03-02 2022-03-02 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +4.5%
29.00
US$145,000 		5,000 +4.5% 29.00 US$145,000
2022-03-03 2022-03-01 B Purchase
1.8
Anand Kapila K
Non-Executive Director
1,000 +3.8%
28.48
US$28,479 		1,000 +3.8% 28.48 US$28,479
2022-03-02 2022-03-01 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +4.8%
28.66
US$143,322 		5,000 +4.8% 28.66 US$143,322
2021-12-02 2021-11-30 B Purchase
2.5
Harrington Michael J
Non-Executive Director
2,500 +9.7%
29.25
US$73,122 		2,500 +9.7% 29.25 US$73,122
2021-12-02 2021-11-30 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
10,000 +10.5%
29.38
US$293,794 		10,000 +10.5% 29.38 US$293,794
2021-11-17 2021-11-15 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +5.6%
31.79
US$158,934 		5,000 +5.6% 31.79 US$158,934
2021-05-12 2021-05-11 B Purchase
2.9
HOOVER R DAVID

See Remarks

Non-Executive Director
25,000 +55.6%
32.44
US$811,000 		25,000 +55.6% 32.44 US$811,000
2020-12-03 2020-12-03 S Sale
1.6
BAYER AKTIENGESELLSCHAFT
Large shareholder
54,500,000 -74.7%
29.84
US$1,626,367,200 		54,500,000 -74.7% 29.84 US$1,626,367,200
2020-08-28 2020-08-28 B Purchase
2.9
HOOVER R DAVID

See Remarks

Non-Executive Director
5,000 +12.5%
28.62
US$143,100 		5,000 +12.5% 28.62 US$143,100
2020-08-28 2020-08-27 B Purchase
2.9
HOOVER R DAVID

See Remarks

Non-Executive Director
5,000 +16.1%
28.24
US$141,200 		5,000 +16.1% 28.24 US$141,200
2020-08-24 2020-08-21 B Purchase
2.9
HOOVER R DAVID

See Remarks

Non-Executive Director
10,000 +47.4%
26.94
US$269,400 		10,000 +47.4% 26.94 US$269,400
2020-08-19 2020-08-19 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
9,580 +65.4%
26.20
US$250,996 		9,580 +65.4% 26.20 US$250,996
2020-08-07 2020-08-06 B Purchase
3.4
GARCIA ART A
Non-Executive Director
2,000 +28.3%
24.76
US$49,520 		2,000 +28.3% 24.76 US$49,520
2020-08-04 2020-08-03 B Purchase
3.6
YOUNG TODD S.

See Remarks

Officer
5,000 +inf%
23.94
US$119,700 		5,000 +inf% 23.94 US$119,700
2020-08-04 2020-08-03 B Purchase
3.6
YOUNG TODD S.

See Remarks

Officer
2,000 +inf%
23.85
US$47,700 		2,000 +inf% 23.85 US$47,700
2020-03-16 2020-03-13 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
12,000 +42.9%
21.97
US$263,640 		12,000 +42.9% 21.97 US$263,640
2020-03-11 2020-03-09 B Purchase
2.5
Harrington Michael J
Non-Executive Director
4,000 +31.3%
23.84
US$95,360 		4,000 +31.3% 23.84 US$95,360
2020-03-06 2020-03-06 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
3,000 +25.8%
25.15
US$75,450 		3,000 +25.8% 25.15 US$75,450
2020-03-06 2020-03-04 B Purchase
1.8
Anand Kapila K
Non-Executive Director
1,000 +8.1%
26.86
US$26,860 		1,000 +8.1% 26.86 US$26,860
2020-03-03 2020-03-02 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
3,900 +16.2%
27.40
US$106,860 		3,900 +16.2% 27.40 US$106,860
2020-03-03 2020-02-28 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
4,100 +20.5%
26.99
US$110,659 		4,100 +20.5% 26.99 US$110,659
2019-11-25 2019-11-22 B Purchase BILBREY JOHN P Non-Executive Director
3,766 +47.8%
26.58
US$100,100 		3,766 +47.8% 26.58 US$100,100
2019-11-20 2019-11-18 B Purchase
2.3
Urbanek David Alan

See Remarks
76 +inf%
26.29
US$1,998 		76 +inf% 26.29 US$1,998
2019-11-20 2019-11-18 B Purchase
2.3
Urbanek David Alan

See Remarks
76 +inf%
26.27
US$1,996 		76 +inf% 26.27 US$1,996
2019-11-20 2019-11-18 B Purchase
2.3
Urbanek David Alan

See Remarks
76 +inf%
26.21
US$1,992 		76 +inf% 26.21 US$1,992
2019-09-12 2019-09-11 B Purchase
2.0
Kochevar Deborah Turner
1,000 +35.9%
27.95
US$27,950 		1,000 +35.9% 27.95 US$27,950
2019-09-05 2019-09-04 B Purchase
3.6
YOUNG TODD S.

See Remarks
10,000 +53.0%
26.57
US$265,700 		10,000 +53.0% 26.57 US$265,700
2019-09-05 2019-09-04 B Purchase
3.5
Simmons Jeffrey N

President, CEO & Director

Executive Director
75,750 +19.2%
26.55
US$2,011,162 		75,750 +19.2% 26.55 US$2,011,162
2019-08-26 2019-08-22 B Purchase Hicks Michael-Bryant

See Remarks

Officer
11,030 +48.2%
26.65
US$293,905 		11,030 +48.2% 26.65 US$293,905
2019-08-26 2019-08-22 B Purchase HOOVER R DAVID Non-Executive Director
15,000 +1630.4%
26.96
US$404,400 		15,000 +1630.4% 26.96 US$404,400
2019-05-15 2019-05-13 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
7,750 +inf%
32.39
US$251,022 		7,750 +inf% 32.39 US$251,022
2019-08-26 2019-04-22 B Purchase Harrington Michael J Non-Executive Director
3,500 +125.8%
26.75
US$93,608 		3,500 +125.8% 26.75 US$93,608
2019-03-14 2019-03-13 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
20,000 +inf%
31.43
US$628,586 		20,000 +inf% 31.43 US$628,586
2019-03-13 2019-03-11 B Purchase
Kinard David S

See Remarks

Officer
7,977
0.00
US$0 		7,977 0.00 US$0
2019-03-13 2019-03-11 B Purchase
Schacht Aaron L

See Remarks

Officer
1,227
0.00
US$0 		1,227 0.00 US$0
2019-03-13 2019-03-11 B Purchase
3.5
Simmons Jeffrey N

Presiident, CEO & Director

Executive Director
37,301
0.00
US$0 		37,301 0.00 US$0
2019-03-13 2019-03-11 B Purchase
2.3
Urbanek David Alan

See Remarks

Officer
2,021
0.00
US$0 		2,021 0.00 US$0
2019-03-13 2019-03-11 B Purchase
Cabral Ramiro Martin

See Remarks

Officer
1,227
0.00
US$0 		1,227 0.00 US$0
2019-03-13 2019-03-11 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
920
0.00
US$0 		920 0.00 US$0
2018-09-26 2018-09-24 B Purchase Meer James M

Chief Accounting Officer
225 +inf%
24.00
US$5,400 		225 +inf% 24.00 US$5,400
2018-09-26 2018-09-24 B Purchase Urbanek David Alan

See Remarks
500 +inf%
24.00
US$12,000 		500 +inf% 24.00 US$12,000
2018-09-26 2018-09-24 B Purchase Anand Kapila K
1,200 +inf%
24.00
US$28,800 		1,200 +inf% 24.00 US$28,800
2018-09-26 2018-09-24 B Purchase Kinard David S

See Remarks
2,500 +inf%
24.00
US$60,000 		2,500 +inf% 24.00 US$60,000
Explore more

More insider trading research around Elanco Animal Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America